Taiwan Advance Bio-Pharmaceutical, Inc.(TW:4186)
NT$7.00+0.05 (+0.72%)
TW:4186
Taiwan Advance Bio-Pharmaceutical, Inc. Revenue
NT$7.00
At close:+0.05 (+0.72%)
Taiwan Advance Bio-Pharmaceutical, Inc. (4186) Revenue
1 Followers
Taiwan Advance Bio-Pharmaceutical, Inc. Revenue
Taiwan Advance Bio-Pharmaceutical, Inc. had a revenue of 153.10M in the quarter ending Jun 30, 2026, with -21.66%. This bring the company's revenue in the last twelve months to 348.54M, Decreased 4.45%. In the fiscal year ending Dec 31, 2025, Taiwan Advance Bio-Pharmaceutical, Inc. had annual revenue of 364.79M with 3.00% growth.
- Revenue (ttm)
- 348.54M
- Revenue Growth
- -6.27%
- P/S Ratio
- 1.71
- Revenue/Employee
- TWD 2,279,938
- Employees
- 160
- Market Cap
- TWD 625.50M
Revenue Chart
Taiwan Advance Bio-Pharmaceutical, Inc. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 364.79M | 10.62M | 3.00% |
| Dec 31, 2024 | 354.17M | 38.19M | 12.09% |
| Dec 31, 2023 | 315.98M | -2.25M | -0.71% |
| Dec 31, 2022 | 318.24M | 74.87M | 30.77% |
| Dec 31, 2021 | 243.36M | 7.79M | 3.31% |
| Dec 31, 2020 | 235.57M | 29.77M | 14.47% |
| Dec 31, 2019 | 205.80M | 37.45M | 22.25% |
| Dec 31, 2018 | 168.35M | 23.29M | 16.05% |
| Dec 31, 2017 | 145.06M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.